Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Long term outcomes in adult heart transplant recipients treated with OKT3 versus daclizumab induction therapy. 7th American Transplant Congress Virani, S. A., Ransohoff, K., Haddad, F., Valantine, H. A., Chin, C. WILEY-BLACKWELL. 2007: 424–424
View details for Web of Science ID 000246370201514